Sputum induction to aid diagnosis of smear-negative or sputum-scarce tuberculosis in adults in HIV-endemic settings

European Respiratory Journal

Volumn 43, Issue 1, 2014, Pages 185-194

  Peter, Jonathan G ^a   Theron, Grant ^a   Singh, Nevanda ^a   Singh, Avani ^a   Dheda, Keertan ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; BACTERIUM CULTURE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENDEMIC DISEASE; FEMALE; HOSPITAL PATIENT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIQUID CULTURE; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MICROSCOPY; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; OUTPATIENT; PREDICTIVE VALUE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM EXAMINATION; SPUTUM SMEAR; TUBERCULOSIS;

ADULT; COINFECTION; ENDEMIC DISEASES; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 84891908248     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00198012     Document Type: Review

References (32)

1. Whitehorn J, Ayles H, Godfrey-Faussett P. Extra-pulmonary and smear-negative forms of tuberculosis are associated with treatment delay and hospitalisation. Int J Tuberc Lung Dis 2010; 14: 741-744.
2. World Health Organization. Global Tuberculosis Control 2011. Geneva, World Heath Organisation, 2011.
3. Banda H, Kang'ombe C, Harries AD, et al. Mortality rates and recurrent rates of tuberculosis in patients with smear-negative pulmonary tuberculosis and tuberculous pleural effusio.who.have completed treatment. Int J Tuberc Lung Dis 2000; 4: 968-974.
4. Harries AD, Nyirenda TE, Banerjee A, et al. Treatment outcome of patients with smear-negative and smear-positive pulmonary tuberculosis in the National Tuberculosis Control Programme, Malawi. Trans R Soc Trop Med Hyg 1999; 93: 443-446.
5. Salaniponi FM, Gausi F, Kwanjana JH, et al. Time between sputum examination and treatment in patients with smear-negative pulmonary tuberculosis. Int J Tuberc Lung Dis 2000; 4: 581-583.
6. Behr MA, Warren SA, Salamon H, et al. Transmission of Mycobacterium tuberculosis from patients smear-negative for acid-fast bacilli. Lancet 1999; 353: 444-449.
7. Tostmann A, Kik SV, Kalisvaart NA, et al. Tuberculosis transmission by patients with smear-negative pulmonary tuberculosis in a large cohort in the Netherlands. Clin Infect Dis 2008; 47: 1135-1142.
8. McIlleron H, Meintjes G, Burman WJ, et al. Complications of antiretroviral therapy in patients with tuberculosis: Drug interactions, toxicity, and immune reconstitution inflammatory syndrome. J Infect Dis 2007; 196: Suppl. 1, S63-S75.
9. Getahun H, Harrington M, O'Brien R, et al. Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: Informing urgent policy changes. Lancet 2007; 369: 2042-2049.
10. World Health Organization. Automated Real-time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System. Geneva, World Health Organization, 2011.
11. Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: A multicentre implementation study. Lancet 2011; 377: 1495-1505.
12. Theron G, Peter J, van Zyl-Smit R, et al. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med 2011; 184: 132-140.
13. Weyer K, Mirzayev F, Migliori GB, et al. Rapid molecular TB diagnosis: Evidence, policy-making and global implementation of Xpert MTB/RIF. Eur Respir J 2013; 42: 252-271.
14. Pantoja A, Fitzpatrick C, Vassall A, et al. Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: A cost and affordability analysis. Eur Respir J 2013; 42: 708-720.
15. Bell DJ, Dacombe R, Graham SM, et al. Simple measures are as effective as invasive techniques in the diagnosis of pulmonary tuberculosis in Malawi. Int J Tuberc Lung Dis 2009; 13: 99-104.
16. Wilson D, Nachega J, Morroni C, et al. Diagnosing smear-negative tuberculosis using case definitions and treatment response in HIV-infected adults. Int J Tuberc Lung Dis 2006; 10: 31-38.
17. Morse M, Kessler J, Albrecht S, et al. Induced sputum improves the diagnosis of pulmonary tuberculosis in hospitalized patients in Gaborone, Botswana. Int J Tuberc Lung Dis 2008; 12: 1279-1285.
18. Parry CM, Kamoto O, Harries AD, et al. The use of sputum induction for establishing a diagnosis in patients with suspected pulmonary tuberculosis in Malawi. Tuber Lung Dis 1995; 76: 72-76.
19. Hepple P, Ford N, McNerney R. Microscopy compared to culture for the diagnosis of tuberculosis in induced sputum samples: A systematic review. Int J Tuberc Lung Dis 2012; 16: 579-588.
20. Gonzalez-Angulo Y, Wiysonge CS, Geldenhuys H, et al. Sputum induction for the diagnosis of pulmonary tuberculosis: A systematic review and meta-analysis. Eur J Clin Microbiol Infect Dis 2012; 31: 1619-1630.
21. Anderson C, Inhaber N, Menzies D. Comparison of sputum induction with fiber-optic bronchoscopy in the diagnosis of tuberculosis. Am J Respir Crit Care Med 1995; 152: 1570-1574.
22. Conde MB, Soares SL, Mello FC, et al. Comparison of sputum induction with fiberoptic bronchoscopy in the diagnosis of tuberculosis: Experience at an acquired immune deficiency syndrome reference center in Rio de Janeiro, Brazil. Am J Respir Crit Care Med 2000; 162: 2238-2240.
23. Zar HJ, Hanslo D, Apolles P, et al. Induced sputum versus gastric lavage for microbiological confirmation of pulmonary tuberculosis in infants and young children: A prospective study. Lancet 2005; 365: 130-134.
24. Hatherill M, Hawkridge T, Zar HJ, et al. Induced sputum or gastric lavage for community-based diagnosis of childhood pulmonary tuberculosis Arch Dis Child 2009; 94: 195-201.
25. Lawn SD, Kerkhoff AD, Pahlana P, et al. Diagnostic yield of tuberculosis using sputum induction in HIV-positive patients before antiretroviral therapy. Int J Tuberc Lung Dis 2012; 16: 1354-1357.
26. Cashmore TJ, Peter JG, van Zyl-Smit RN, et al. Feasibility and diagnostic utility of antigen-specific interferongamma responses for rapid immunodiagnosis of tuberculosis using induced sputum. PLoS One 2010; 5: E10389.
27. Bartlett RC. Medical Microbiology: Quality, Cost and Clinical Relevance. New York, John Wiley and Sons, 1974.
28. De Wit D, Steyn L, Shoemaker S, et al. Direct detection of Mycobacterium tuberculosis in clinical specimens by DNA amplification. J Clin Microbiol 1990; 28: 2437-2341.
29. Knottnerus JA, van Weel C, Muris JW. Evaluation of diagnostic procedures. BMJ 2002; 324: 477-480.
30. Lawn SD, Kerkhoff AD, Pahlana P, et al. Diagnostic yield of tuberculosis using sputum induction in HIV-positive patients before antiretroviral therapy. Int J Tuberc Lung Dis 2012; 16: 1354-1357.
31. Gupta A, Wood R, Kaplan R, et al. Tuberculosis incidence rates duringg years of follow-up of an antiretroviral treatment cohort in South Africa: Comparison with rates in the community. PLoS One 2012; 7: E34156.
32. Finnie RK, Khoza LB, van den Borne B, et al. Factors associated with patient and health care system delay in diagnosis and treatment for TB in sub-Saharan African countries with high burdens of TB and HIV. Trop Med Int Health 2011; 16: 394-411.